CRYSTAL ADAM (President, R&D) sold 19.3% of their position (27K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $572.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2026ACC: 0001193125-26-140874
Officer· President, R&D
Since Feb 2026
-27K
Net shares
Net seller
$572.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
27K acquired · 54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27K
Price / share
$5.20
Trade value
$140.40K
% of position
24.0%
4/1/2026
112.62K→139.62K
Common Stock
Direct
Shares
−27K
Price / share
$21.20
Trade value
$572.48K
% of position
19.3%
4/1/2026
139.62K→112.62K
Total
Net shares
+0.00
Net value
-$432.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +27K | $5.20 | $140.40K | 24.0% | 112.62K | 139.62K |
| Common Stock Direct | 4/1/2026 | S · Sale | −27K | $21.20 | $572.48K | 19.3% | 139.62K | 112.62K |
| Total | +0.00 | -$432.08K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27K shares
Shares
−27K
Strike price
5.2
Held after
433.50K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 4/1/2026 | M · Option Exercise | −27K | 5.2 | — | 433.50K |